Item 9 Labs Corp (INLB)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 01, 14:27
Item 9 Labs Shareholders Equity (Quarterly): 52.65M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 52.65M |
| March 31, 2023 | 57.68M |
| December 31, 2022 | 60.37M |
| September 30, 2022 | 61.96M |
| June 30, 2022 | 78.49M |
| March 31, 2022 | 82.74M |
| December 31, 2021 | 84.46M |
| September 30, 2021 | 86.10M |
| June 30, 2021 | 135.61M |
| March 31, 2021 | 138.16M |
| December 31, 2020 | 13.20M |
| September 30, 2020 | 8.015M |
| June 30, 2020 | 10.96M |
| March 31, 2020 | 11.09M |
| December 31, 2019 | 5.717M |
| September 30, 2019 | 7.460M |
| June 30, 2019 | 14.07M |
| September 30, 2018 | 2.618M |
| March 31, 2018 | 2.761M |
| December 31, 2017 | -1.839M |
| September 30, 2017 | 0.9686M |
| June 30, 2017 | -2.177M |
| March 31, 2017 | -2.191M |
| Date | Value |
|---|---|
| December 31, 2016 | -2.166M |
| September 30, 2016 | -2.073M |
| June 30, 2016 | -5.265M |
| March 31, 2016 | -5.045M |
| December 31, 2015 | -5.042M |
| September 30, 2015 | -4.985M |
| June 30, 2015 | -4.148M |
| March 31, 2015 | -3.560M |
| December 31, 2014 | -2.939M |
| September 30, 2014 | -2.636M |
| June 30, 2014 | -2.309M |
| March 31, 2014 | -2.020M |
| December 31, 2013 | -3.751M |
| September 30, 2013 | -2.938M |
| June 30, 2013 | -2.758M |
| March 31, 2013 | -2.493M |
| December 31, 2012 | -2.385M |
| June 30, 2012 | -2.546M |
| March 31, 2012 | 21.14M |
| December 31, 2011 | -0.005M |
| September 30, 2011 | -0.0492M |
| December 31, 2010 | -0.0228M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.717M
Minimum
Dec 2019
138.16M
Maximum
Mar 2021
53.46M
Average
57.68M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Cantabio Pharmaceuticals Inc | -1.889M |
| Q BioMed Inc | -6.441M |
| NVN Liquidation Inc | -2.828M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | -9.452M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 112.02M |
| Total Liabilities (Quarterly) | 59.37M |
| Debt to Equity Ratio | 0.6439 |
| Current Ratio | 0.0569 |
| Net Debt Paydown Yield | -30.33% |